Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients(493 views) Erro R, Pappata S, Amboni M, Vicidomini C, Longo K, Santangelo G, Picillo M, Vitale C, Moccia M, Giordano F, Brunetti A, Pellecchia MT, Salvatore M, Barone P
Keywords: 123-I-Fp-Cit Spect, Anxiety, De Novo, Dopamine Transporter, Mood, Parkinson, S Disease, Fp Cit I 123, Radiopharmaceutical Agent, Unclassified Drug, Adult, Anxiety Disorder, Article, Bioavailability, Caudate Nucleus, Clinical Article, Controlled Study, Disease Severity, Female, Human, Nigroneostriatal System, Parkinson Disease, Priority Journal, Putamen, Single Photon Emission Computer Tomography, Case-Control Studies, Corpus Striatum, Dopamine Plasma Membrane Transport Proteins, Follow-Up Studies, Functional Laterality, Middle Aged, Psychiatric Status Rating Scales, Regression Analysis, Severity Of Illness Index, Emission-Computed, Single-Photon, Tropanes,
Affiliations: *** IBB - CNR ***
University Federico II, Department of Neurological Science, Naples, Italy.
Institute of Biostructure and Bioimaging, CNR, Naples, Italy
IDC Hermitage - Capodimonte, Italy
Neuropsychology Laboratory, Department of Psychology, Second University of Naples, Caserta, Italy
University Parthenope, Naples, Italy
University of Salerno, Center for neurodegenerative diseases - CEMAND, Via S. Allende, 84081 Baronissi (SA), Italy
References: Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, Henn, F., Frequency of dementia, depression, and other neuropsychiatric symptoms in 1449 outpatients with Parkinson's disease (2010) J Neurol, 257, pp. 1073-108
Dissanayaka, N.N.W., Sellbach, A., Matheson, S., O'Sullivan, J.D., Silburn, P.A., Byrne, G.J., Anxiety disorders in Parkinson's disease: prevalence and risk factors (2010) Mov Disord, 25 (7), pp. 838-845
Leentjens, A.F.G., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I.H., Starkstein, S.E., Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study (2011) Mov Disord, 26 (3), pp. 484-492
Pontone, G.M., Williams, J.R., Anderson, K.E., Chase, G., Goldstein, S.R., Grill, S., Anxiety and self-perceived health status in Parkinson's disease (2011) Parkinsonism and Relat Disord, 17, pp. 249-254
Siemers, E.R., Shekhar, A., Quaid, K., Dickson, H., Anxiety and motor performance in Parkinson's disease (1993) Mov Disord, 8, pp. 501-506
Vazquez, A., Jimenez-Jimenez, F.J., Garcia-Ruiz, P., Garcia-Urra, D., " Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy (1993) Acta Neurol Scand, 87, pp. 14-18
Lauterbach, E.C., Freeman, A., Vogel, R.L., Correlates of generalized anxiety and panic attacks in dystonia and Parkinson's disease (2003) Cogn Behav Neurol, 16, pp. 225-233
Henderson, R., Kurlan, R., Kersun, J.M., Como, P., Preliminary examination of anxiety and depression in Parkinson's disease (1992) J Neuropsychiatry Clin Neurosci, 4, pp. 257-264
Maricle, R.A., Nutt, J.G., Valentine, R.J., Carter, J.H., Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double- blind, placebo-controlled study (1995) Neurology, 45, pp. 1757-1760
Davidson, R.J., Anxiety and affective style. Role of prefrontal cortex and amygdala (2002) Biol Psychiatry, 51, pp. 68-80
Kaasinen, V., Nurmi, E., Bergman, J., Eskola, O., Sollin, O., Sonninen, P., Personality traits and brain dopaminergic function in Parkinson's disease (2001) Proc Natl Acad Sci USA, 98, pp. 13272-13277
Weintraub, D., Newberg, A.B., Cary, M.S., Siderowf, A.D., Moberg, P.J., Kleiner-Fismn, G., Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease (2005) J Nucl Med, 46, pp. 227-232
Moriyama, T.S., Felicio, A.C., Chagas, M.H.N., Tardelli, V.S., Ferraz, H.B., Tumas, V., Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder (2011) J Neurol Sci, 310, pp. 53-57
Sossi, V., de la Fuente-Fernandez, R., Schulzer, M., Troiano, A.R., Ruth, T.J., Stoessl, A.J., Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study (2007) Ann Neurol, 62 (5), pp. 468-474
Pappatà, S., Santangelo, G., Aarsland, D., Vicidomini, C., Longo, K., Bronnick, K., Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism (2011) Neurology, 77 (14), pp. 1357-1362
Fahn, S., Elton, R.L., Unified Parkinson's disease rating scale (1987) Recent developments in Parkinson's disease, 2, pp. 153-163. , UPDRS program members Macmillan Healthcare information, Florham Park. NJ
Booij, J., Hemelaar, T.G., Speelman, J.D., de Bruin, K., Janssen, A.G., van Royen, E.A., One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123]FPCIT SPECT (1999) J Nucl Med, 40 (5), pp. 753-761
Varrone, A., Pellecchia, M.T., Amboni, M., Sansone, V., Salvatore, E., Ghezzi, D., Imaging of dopaminergic dysfunction with 123I-FP-CIT SPECT in early-onset parkin disease (2004) Neurology, 63 (11), pp. 2097-2103
Kaasinen, V., Rinne, J.O., Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease (2002) Neurosci Biobehav Rev, 26, pp. 785-793
Muller, U., Wachter, T., Barthel, H., Reuter, M., von Cramon, D.Y., Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease (2000) J Neural Transm, 107 (3), pp. 303-319
Rektorova, I., Srovnalova, H., Kubikova, R., Prasek, J., Striatal dopamine transporter imaging correlates with depressive symptoms and Tower of London task performance in Parkinson's disease (2008) Mov Disord, 23 (11), pp. 1580-1587
Qiu, C., Liao, W., Ding, J., Feng, Y., Zhu, C., Nie, X., Regional homogeneity changes in social anxiety disorder: a resting-state fMRI study (2011) Psychiatry Res, 194 (1), pp. 47-53
Foster, P.S., Drago, V., Crucian, G.P., Sullivan, W.K., Rhodes, R.D., Shenal, B.V., Anxiety and depression severity are related to right but not left onset Parkinson's disease duration (2011) J Neurol Sci, 305, pp. 131-135
Koerts, J., Leenders, K.L., Koning, M., Portman, A.T., van Beilen, M., Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease (2007) Eur J Neurosci, 25, pp. 3132-3136
Barone, P., Poewe, W., Albrecht, S., Debleuvre, C., Massey, D., Rascol, O., Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2010) Lancet Neurol, 9 (6), pp. 573-580
Kano, O., Ikeda, K., Cridebring, D., Takazawa, T., Yoshii, Y., Iwasaki, Y., Neurobiology of depression and anxiety in Parkinson's disease (2011) Parkinsons Dis, , Published online
Jaunarajs, K.L.E., Angoa-Perez, M., Kuhn, D.M., Bishop, C., Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment (2011) Neurosci Biobehav Rev, 35 (3), pp. 556-564
Ziebell, M., Holm-Hansen, S., Thomsen, G., Wagner, G., Jensen, P., Pinborg, L.H., Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I (2010) J Nucl Med, 51 (12), pp. 1885-1891
Booij, J., de Jong, J., de Bruin, K., Knol, R., de Win, M.M., van Eck-Smit, B.L., Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo controlled, crossover study in healthy control subjects (2007) J Nucl Med, 48 (3), pp. 359-366
Beucke, J.C., Plotkin, M., Winter, C., Endrass, T., Amthauer, H., Juckel, G., Midbrain serotonin transporters in de novo and L-DOPA-treated patients with early Parkinson's disease-a [123 I]-ADAM SPECT study (2011) Eur J Neurol, 18 (5), pp. 750-755
Strecker, K., Wegner, F., Hesse, S., Becker, G.A., Patt, M., Meyer, P.M., Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter (2011) J Neurol, 258 (1), pp. 19-26. , Epub 2010 Jul 21
Bower, J.H., Grossardt, B.R., Maraganore, D.M., Ahlskog, J.E., Colligan, R.C., Geda, Y.E., Anxious personality predicts an increased risk of Parkinson's disease (2010) Mov Disord, 25 (13), pp. 2105-2113
Bogdanova, Y., Cronin-Golomb, A., Neurocognitive correlates of apathy and anxiety in Parkinson's disease (2012) Parkinsons Dis, , Published online
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients
BACKGROUND: Anxiety is a common non-motor symptom among patients with Parkinson's disease (PD). Although the etiology of anxiety in PD is likely to be multifactorial, a dysfunction in the dopaminergic system might be implicated in its pathogenesis. The aim of our study was to investigate a possible dopaminergic mechanism involved in anxiety in newly diagnosed never-medicated PD patients using SPECT and I-FP-CIT as the dopamine transporter ligand.; METHODS: Thirty-four newly diagnosed, untreated PD patients with asymmetric motor symptoms were included in the study: 17 patients with right- and 17 with left-motor onset, matched for age, disease duration and motor disability constituted the group. They were all evaluated for anxiety and depression and underwent an SPECT with I-FP-CIT. Dopamine transporter (DAT) availability values for right and left caudate and putamen were calculated and compared between patients with and without anxiety. Regression analyses were also performed in order to correlate DAT availability with the severity of the anxiety symptoms.; RESULTS: Comparison between PD patients with and those without anxiety revealed significant differences of DAT availability in all the examined regions except the right putamen. In the group of patients considered as a whole, a significant correlation was found between increased anxiety severity and decreased DAT availability in right caudate.; CONCLUSIONS: We reported an association between nigrostriatal DAT availability deficits and anxiety symptoms in newly diagnosed, untreated PD patients. Our results suggest that hypofunction of the nigrostriatal dopaminergic system may represent one of the functional anomalies involved in anxiety in PD from the earliest stages of disease and irrespective of any therapy. 2012 Elsevier Ltd. All rights reserved.
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients
No results.
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote